Pharmacokinetics of methadone

RA Lugo, KL Satterfield, SE Kern - Journal of Pain & Palliative …, 2005 - Taylor & Francis
Methadone is a synthetic opioid that is effective for the relief of moderate-to-severe pain and
for the treatment of opioid dependence. The pharmacokinetics of methadone differ from …

Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics

DR Brocks - Biopharmaceutics & drug disposition, 2006 - Wiley Online Library
Many marketed drugs are chiral and are administered as the racemate, a 50: 50
combination of two enantiomers. Pharmacodynamic and pharmacokinetic differences …

Clinical pharmacology of methadone for pain

OMS Fredheim, K Moksnes… - Acta …, 2008 - Wiley Online Library
Background: This topical review addresses methadone's pharmacology, its application in
malignant and non‐malignant pain conditions, practical issues related to methadone for the …

[PDF][PDF] Metabolism and disposition of prescription opioids: a review

AZ DePriest, BL Puet, AC Holt… - Forensic Sci …, 2015 - forensicsciencereview.com
Opioid analgesics are commonly prescribed for acute and chronic pain, but are subject to
abuse. Consequently, toxicology testing programs are frequently implemented for both …

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid …

M Soyka, HR Kranzler, W van den Brink… - The world journal of …, 2011 - Taylor & Francis
Objectives. To develop evidence-based practice guidelines for the pharmacological
treatment of opioid abuse and dependence. Methods. An international task force of the …

ABCB1 genetic variability and methadone dosage requirements in opioid‐dependent individuals

JK Coller, DT Barratt, K Dahlen… - Clinical …, 2006 - Wiley Online Library
Background and Objectives The most common treatment for opioid dependence is
substitution therapy with another opioid such as methadone. The methadone dosage is …

Changes to methadone clearance during pregnancy

K Wolff, A Boys, A Rostami-Hodjegan, A Hay… - European journal of …, 2005 - Springer
Objective Measurement of plasma methadone concentration to investigate the rate of
clearance of methadone prescribed for heroin dependence in the first, second and third …

Methadone pharmacokinetics are independent of cytochrome P4503A (CYP3A) activity and gastrointestinal drug transport: insights from methadone interactions with …

ED Kharasch, C Hoffer, D Whittington… - …, 2009 - pmc.ncbi.nlm.nih.gov
Background Methadone clearance is highly variable and drug interactions are problematic.
Both have been attributed to CYP3A, but actual mechanisms are unknown. Drug interactions …

The pharmacokinetics of methadone and its metabolites in neonates, infants, and children

RM Ward, DR Drover, GB Hammer… - Pediatric …, 2014 - Wiley Online Library
Background The lack of methadone pharmacokinetic data in children and neonates
restrains dosing to achieve the target concentration in these populations. A minimum …

Characterization of the safety and pharmacokinetic profile of D-methadone, a novel N-methyl-D-aspartate receptor antagonist in healthy, opioid-naive subjects: results …

G Bernstein, K Davis, C Mills, L Wang… - Journal of Clinical …, 2019 - journals.lww.com
Methods We conducted 2 phase 1, double-blind, randomized, placebo-controlled, single-
and multiple-ascending-dose studies to investigate the safety and tolerability of oral d …